GLP-1 RA functions by activating the GLP-1 receptor (GLP-1R), and GLP-1R is widely located throughout the brain.6,7 The ability of GLP-1 and its agonists to cross the bloodbrain barrier810 suggests its therapeutic potential for NDs
Naltrexone-Bupropion is a combination of a mild inhibitor of dopamine and norepinephrine reuptake (Bupropion) with an agonist of the -opioid receptor (Naltrexone) that acts synergistically to activate pro-opiomelanocortin (POMC) neurons in the hypothalamic, in particular in the neurons in the arcuate nucleus (ARC), resulting in appetite suppression [96, 97]
What actually works right now: the unsexy answer If youre on a GLP-1 drug today or considering one and youre worried about muscle loss, heres the reality: the myostatin inhibitors arent available yet, the trials are early-stage, and even the most promising candidate (apitegromab) hasnt shown functional strength benefits
Step 3: Our Office Completes the Prior Authorization Once we receive the request, our team completes the prior authorization form
Spending money on Lipo B while forgoing tirzepatide is biochemically backwards
